Home / Resources / Strategic Leadership resources

战略领导力

精选资源

Early Systematic PICO Scenario Identification and Prioritization for EU HTA Joint Clinical Assessments

海报

Upcoming strategic leadership webinars

网络研讨会

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

2025 年 12 月 16 日 – 11:00am - 12:00pm ET

Popular resources

博客

From Insight to Impact: Certainty EMEA 2025

公告

Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software

公告

Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs

Fact Sheet, Guide

New Approach Methodologies (NAMs): By the numbers

网络研讨会点播

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

事实资料表

Build investor confidence with science-backed strategy

在以下活动中与我们的专家会面

会议

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

January 12 - 16, 2026 – San Francisco, CA

All Strategic Leadership resources

Expedited Pharmacometrics Regulatory Submissions

Clinical Pharmacology, Clinical Trials, Model Informed Drug Development, Modeling and Simulation, Fact Sheet

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

Certara Services, Modeling and Simulation, Pediatrics, Blog

From Insight to Impact: Certainty EMEA 2025

Certara Products, Certara Services, Blog

New Approach Methodologies (NAMs): By the numbers

Certara Services, Modeling and Simulation, New Approach Methodologies (NAMs), Fact Sheet, Guide

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, On-Demand Webinar

Build investor confidence with science-backed strategy

Certara Services, Fact Sheet

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Certara Services, Clinical Trials, Drug Development, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Publication

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

战略领导力

最新资源

Expedited Pharmacometrics Regulatory Submissions

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

精选资源

Early Systematic PICO Scenario Identification and Prioritization for EU HTA Joint Clinical Assessments

Upcoming strategic leadership webinars

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Popular resources

From Insight to Impact: Certainty EMEA 2025

Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software

Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs

New Approach Methodologies (NAMs): By the numbers

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Build investor confidence with science-backed strategy

在以下活动中与我们的专家会面

JPM 2026 44th Annual Healthcare Conference & Biotech Showcase

All Strategic Leadership resources

Expedited Pharmacometrics Regulatory Submissions

The Stepwise PIP is Here to Stay: From Pilot Flexibility to Permanent EU Regulation

From Insight to Impact: Certainty EMEA 2025

New Approach Methodologies (NAMs): By the numbers

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Build investor confidence with science-backed strategy

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

At Certara, we’re proud to support WBUR, Boston’s NPR.

U.S. International Reference Pricing: Global Implications and Pharma Strategy

Redefining Every Stage of Investment (RESI) Seed to Exit

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

订阅时事通讯

快捷链接

解决方案

联系我们